Zevra Therapeutics announced the publication of “Arimoclomol in infants with Niemann-Pick disease type C: Results from the phase 2/3 open-label pediatric substudy” in Molecular Genetics and Metabolism Reports…. read more.
According to the EMA website, on 23 July 2026, the CHMP adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Lynavoy, intended… read more.
Johnson & Johnson announced that the FDA has granted De Novo authorization for the OTTAVA Robotic Surgical System, the world’s first table-integrated soft tissue robotic system. The system… read more.
Artificial intelligence is becoming increasingly powerful at reading pathology slides. But a new Perspective in Science Bulletin argues that accuracy alone is not enough. For AI to truly help pathologists,… read more.
A long-running debate over prescription drug costs has centered on whether drug manufacturers are better rewarded for truly innovative medicines or so-called “me-too” drugs that may offer only… read more.
Viatris Inc. announced that the FDA has approved Gwyn Lo (norelgestromin and ethinyl estradiol transdermal system). Gwyn Lo is a new combined hormonal contraceptive patch with low-dose estrogen…. read more.
BioMarin Pharmaceutical Inc. announced that the U.S. Food and Drug Administration has accepted the company’s supplemental New Drug Application for Voxzogo (vosoritide) for full approval in children with… read more.
Otsuka announced that the FDA has granted approval of SIMTRIYO (centanafadine), a once-daily extended-release capsule for the treatment of attention-deficit hyperactivity disorder in adults and pediatric patients aged… read more.
Eisai Co., Ltd. announced that the European Medicines Agency has accepted for evaluation a marketing authorization application for its in-house-discovered and developed orexin receptor antagonist lemborexant for the… read more.
Researchers have developed a breath detector with a chemical sensor that sniffs out when your body is burning fat through a single exhale. Reporting on July 22 in the Cell Press journal Device, the… read more.
A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by focusing on the effects of excess adiposity on organs and… read more.
NICE (UK): NICE is unable to make a recommendation about the use in the NHS of netarsudil for treating open-angle glaucoma or ocular hypertension in adults. This is… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
